A role of macrophage complement receptor crig in immune clearance and inflammation

Molecular Immunology

Volumn 45, Issue 16, 2008, Pages 4041-4047

  He, Jeannie Q ^a   Wiesmann, Christian ^a   van Lookeren Campagne, Menno ^a  

^a GENENTECH INC   (United States)

Author keywords

Complement; Crig; Vsig4; Z39Ig

Indexed keywords

COMPLEMENT COMPONENT C3B RECEPTOR; COMPLEMENT RECEPTOR; CR1 PROTEIN, HUMAN;

ANIMAL; BIOLOGICAL MODEL; CHEMISTRY; GENETICS; HUMAN; IMMUNOLOGY; INFLAMMATION; MACROPHAGE; METABOLISM; REVIEW;

ANIMALS; HUMANS; INFLAMMATION; MACROPHAGES; MODELS, IMMUNOLOGICAL; RECEPTORS, COMPLEMENT; RECEPTORS, COMPLEMENT 3B;

EID: 55949119669     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2008.07.011     Document Type: Review

References (81)

1. Ahearn, J.M., Fischer, M.B., Croix, D., Goerg, S., Ma, M., Xia, J., Zhou, X., Howard, R.G., Rothstein, T.L., Carroll, M.C., 1996. Disruption of the Cr2 locus results in a reduction in B-1a cells and in an impaired B cell response to T-dependent antigen. Immunity 4, 251-262.
2. Ahn, J.H., Lee, Y., Jeon, C., Lee, S.J., Lee, B.H., Choi, K.D., Bae, Y.S., 2002. Identification of the genes differentially expressed in human dendritic cell subsets by cDNA subtraction and microarray analysis. Blood 100, 1742-1754.
3. Barreiro, O., de la Fuente, H., Mittelbrunn, M., Sanchez-Madrid, F., 2007. Functional insights on the polarized redistribution of leukocyte integrins and their ligands during leukocyte migration and immune interactions. Immunol. Rev. 218, 147-164.
4. Bilzer, M., Roggel, F., Gerbes, A.L., 2006. Role of Kupffer cells in host defense and liver disease. Liver Int. 26, 1175-1186.
5. Botto, M., Dell'Agnola, C., Bygrave, A.E., Thompson, E.M., Cook, H.T., Petry, F., Loos, M., Pandolfi, P.P., Walport, M.J., 1998. Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat. Genet. 19, 56-59.
6. Bowness, P., Davies, K.A., Norsworthy, P.J., Athanassiou, P., Taylor-Wiedeman, J., Borysiewicz, L.K., Meyer, P.A.R., Walport, M.J., 1994. Hereditary C1q deficiency and systemic lupus erythematosus 87, 455-464.
7. Caron, E., Hall, A., 1998. Identification of two distinct mechanisms of phagocytosis controlled by different Rho GTPases. Science 282, 1717-1721.
8. Carroll, M.C., 2004a. The complement system in regulation of adaptive immunity. Nat. Immunol. 5, 981-986.
9. Carroll, M.C., 2004b. A protective role for innate immunity in systemic lupus erythematosus. Nat. Rev. Immunol. 4, 825-831.
10. Carter, R.H., Fearon, D.T., 1992. CD19: lowering the threshold for antigen receptor stimulation of B lymphocytes. Science 256, 105-107.
11. Chen, Z., Koralov, S.B., Kelsoe, G., 2000. Complement C4 inhibits systemic autoimmunity through a mechanism independent of complement receptors CR1 and CR2. J. Exp. Med. 192, 1339-1352.
12. Condeelis, J., Pollard, J.W., 2006. Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell 124, 263-266.
13. Cook, H.T., Botto, M., 2006. Mechanisms of disease: the complement system and the pathogenesis of systemic lupus erythematosus. Nat. Clin. Pract. Rheumatol. 2, 330-337.
14. Cornacoff, J.B., Hebert, L.A., Smead, W.L., VanAman, M.E., Birmingham, D.J., Waxman, F.J., 1983. Primate erythrocyte-immune complex-clearing mechanism. J. Clin. Invest. 71, 236-247.
15. Couturier, C., Haeffner-Cavaillon, N., Weiss, L., Fischer, E., Kazatchkine, M.D., 1990. Induction of cell-associated interleukin 1 through stimulation of the adhesionpromoting proteins LFA-1 (CD11a/CD18) and CR3 (CD11b/CD18) of human monocytes. Eur. J. Immunol. 20, 999-1005.
16. Croize, J., Arvieux, J., Berche, P., Colomb, M.G., 1993. Activation of the human complement alternative pathway by Listeria monocytogenes: evidence for direct binding and proteolysis of the C3 component on bacteria. Infect. Immun. 61, 5134-5139.
17. de Luca, C., Olefsky, J.M., 2008. Inflammation and insulin resistance. FEBS Lett. 582, 97-105.
18. Diamond, M.S., Garcia-Aguilar, J., Bickford, J.K., Corbi, A.L., Springer, T.A., 1993. The I domain is a major recognition site on the leukocyte integrin Mac-1 (CD11b/CD18) for four distinct adhesion ligands. J. Cell Biol. 120, 1031-1043.
19. Dupuy, A.G., Caron, E., 2008. Integrin-dependent phagocytosis-spreading from microadhesion to new concepts. J. Cell Sci. 121, 1773-1783.
20. Edwards, A.O., Ritter 3rd, R., Abel, K.J., Manning, A., Panhuysen, C., Farrer, L.A., 2005. Complement factor H polymorphism and age-related macular degeneration. Science 308, 421-424.
21. Egner, W., 2000. The use of laboratory tests in the diagnosis of SLE. J. Clin. Pathol. 53, 424-432.
22. Fearon, D.T., 1980. Identification of themembrane glycoprotein that is the C3b receptor of the human erythrocyte, polymorphonuclear leukocyte, B lymphocyte, and monocyte. J. Exp. Med. 152, 20-30.
23. Fishelson, Z., Pangburn, M.K., Muller-Eberhard, H.J., 1984. Characterization of the initial C3 convertase of the alternative pathway of human complement. J. Immunol. 132, 1430-1434.
24. Gakidis, M.A., Cullere, X., Olson, T., Wilsbacher, J.L., Zhang, B., Moores, S.L., Ley, K., Swat, W., Mayadas, T., Brugge, J.S., 2004.Vav GEFs are required for beta2 integrindependent functions of neutrophils. J. Cell Biol. 166, 273-282.
25. Gasque, P., 2004. Complement: a unique innate immune sensor for danger signals. Mol. Immunol. 41, 1089-1098.
26. Gordon, D.L., Rice, J., Finlay-Jones, J.J., McDonald, P.J., Hostetter, M.K., 1988. Analysis of C3 deposition and degradation on bacterial surfaces after opsonization. J. Infect. Dis. 157, 697-704.
27. Gordon, S., Taylor, P.R., 2005. Monocyte and macrophage heterogeneity. Nat. Rev. Immunol. 5, 953-964.
28. Gotze, O., Muller-Eberhard, H.J., 1976. The alternative pathway of complement activation. Adv. Immunol. 24, 1-35.
29. Gregory, S.H., Cousens, L.P., van Rooijen, N., Dopp, E.A., Carlos, T.M., Wing, E.J., 2002. Complementary adhesion molecules promote neutrophil-Kupffer cell interaction and the elimination of bacteria taken up by the liver. J. Immunol. 168, 308-315.
30. Hageman, G.S., Anderson, D.H., Johnson, L.V., Hancox, L.S., Taiber, A.J., Hardisty, L.I., Hageman, J.L., Stockman, H.A., Borchardt, J.D., Gehrs, K.M., Smith, R.J., Silvestri, G., Russell, S.R., Klaver, C.C., Barbazetto, I., Chang, S., Yannuzzi, L.A., Barile, G.R., Merriam, J.C., Smith, R.T., Olsh, A.K., Bergeron, J., Zernant, J., Merriam, J.E., Gold, B., Dean, M., Allikmets, R., 2005. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc. Natl. Acad. Sci. U.S.A. 102, 7227-7232.
31. Haines, J.L., Hauser, M.A., Schmidt, S., Scott, W.K., Olson, L.M., Gallins, P., Spencer, K.L., Kwan, S.Y., Noureddine, M., Gilbert, J.R., Schnetz-Boutaud, N., Agarwal, A., Postel, E.A., Pericak-Vance, M.A., 2005. Complement factor H variant increases the risk of age-related macular degeneration. Science 308, 419-421.
32. Hannan, J., Young, K., Szakonyi, G., Overduin, M.J., Perkins, S.J., Chen, X., Holers, V.M., 2002. Structure of complement receptor (CR) 2 and CR2-C3d complexes. Biochem. Soc. Trans. 30, 983-989.
33. Harley, J.B., Alarcon-Riquelme, M.E., Criswell, L.A., Jacob, C.O., Kimberly, R.P., Moser, K.L., Tsao, B.P., Vyse, T.J., Langefeld, C.D., Nath, S.K., Guthridge, J.M., Cobb, B.L., Mirel, D.B., Marion, M.C., Williams, A.H., Divers, J., Wang, W., Frank, S.G., Namjou, B., Gabriel, S.B., Lee, A.T., Gregersen, P.K., Behrens, T.W., Taylor, K.E., Fernando, M., Zidovetzki, R., Gaffney, P.M., Edberg, J.C., Rioux, J.D., Ojwang, J.O., James, J.A., Merrill, J.T., Gilkeson, G.S., Seldin, M.F., Yin, H., Baechler, E.C., Li, Q.Z., Wakeland, E.K., Bruner, G.R., Kaufman, K.M., Kelly, J.A., 2008. Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. Nat. Genet. 40, 204-210.
34. Hayden, M.S., West, A.P., Ghosh, S., 2006. NF-kappaB and the immune response. Oncogene 25, 6758-6780.
35. Helmy, K.Y., Katschke Jr., K.J., Gorgani, N.N., Kljavin, N.M., Elliott, J.M., Diehl, L., Scales, S.J., Ghilardi, N., van Lookeren Campagne, M., 2006. CRIg: a macrophage complement receptor required for phagocytosis of circulating pathogens. Cell 124, 915-927.
36. Hinglais, N., Kazatchkine, M.D., Mandet, C., Appay, M.D., Bariety, J., 1989. Human liver Kupffer cells express CR1, CR3, and CR4 complement receptor antigens. An immunohistochemical study. Lab. Invest. 61, 509-514.
37. Hom, G., Graham, R.R., Modrek, B., Taylor, K.E., Ortmann, W., Garnier, S., Lee, A.T., Chung, S.A., Ferreira, R.C., Pant, P.V., Ballinger, D.G., Kosoy, R., Demirci, F.Y., Kamboh, M.I., Kao, A.H., Tian, C., Gunnarsson, I., Bengtsson, A.A., Rantapaa-Dahlqvist, S., Petri, M., Manzi, S., Seldin, M.F., Ronnblom, L., Syvanen, A.C., Criswell, L.A., Gregersen, P.K., Behrens, T.W., 2008. Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX. N. Engl. J. Med. 358, 900-909.
38. Janssen, B.J., Gros, P., 2007. Structural insights into the central complement component C3. Mol. Immunol. 44, 3-10.
39. Kaplan, G., 1977. Differences in the mode of phagocytosis with Fc and C3 receptors in macrophages. Scand. J. Immunol. 6, 797-807.
40. Katschke Jr., K.J., Helmy, K.Y., Steffek, M., Xi, H., Yin, J., Lee, W.P., Gribling, P., Barck, K.H., Carano, R.A., Taylor, R.E., Rangell, L., Diehl, L., Hass, P.E., Wiesmann, C., van Lookeren Campagne, M., 2007. A novel inhibitor of the alternative pathway of complement reverses inflammation and bone destruction in experimental arthritis. J. Exp. Med. 204, 1319-1325.
41. Kim, D.D., Miwa, T., Kimura, Y., Schwendener, R.A., van Lookeren Campagne, M., Song, W.-C., 2008. Deficiency of DAF and Crry on murine platelets leads to complement-dependent clearance via the macrophage phagocytic receptor CRIg, p. blood-2008-01-134304.
42. Kim, J.K., Choi, E.M., Shin, H.I., Kim, C.H., Hwang, S.H., Kim, S.M., Kwon, B.S., 2005. Characterization of monoclonal antibody specific to the Z39Ig protein, amember of immunoglobulin superfamily. Immunol. Lett. 99, 153-161.
43. Klein, R.J., Zeiss, C., Chew, E.Y., Tsai, J.Y., Sackler, R.S., Haynes, C., Henning, A.K., SanGiovanni, J.P., Mane, S.M., Mayne, S.T., Bracken, M.B., Ferris, F.L., Ott, J., Barnstable, C., Hoh, J., 2005. Complement factor H polymorphism in age-related macular degeneration. Science 308, 385-389.
44. Korb, L.C., Ahearn, J.M., 1997. C1q binds directly and specifically to surface blebs of apoptotic human keratinocytes: complement deficiency and systemic lupus erythematosus revisited. J. Immunol. 158, 4525-4528.
45. Krych-Goldberg, M., Atkinson, J.P., 2001. Structure-function relationships of complement receptor type 1. Immunol. Rev. 180, 112-122.
46. Krych, M., Atkinson, J.P., Holers, V.M., 1992. Complement receptors. Curr. Opin. Immunol. 4, 8-13.
47. Kurtz, C.B., O'Toole, E., Christensen, S.M., Weis, J.H., 1990. The murine complement receptor gene family. IV. Alternative splicing of Cr2 gene transcripts predicts two distinct gene products that share homologous domains with both human CR2 and CR1. J. Immunol. 144, 3581-3591.
48. Langnaese, K., Colleaux, L., Kloos, D.U., Fontes, M., Wieacker, P., 2000. Cloning of Z39Ig, a novel gene with immunoglobulin-like domains located on human chromosome X. Biochim. Biophys. Acta 1492, 522-525.
49. Lee, M.Y., Kim, W.J., Kang, Y.J., Jung, Y.M., Kang, Y.M., Suk, K., Park, J.E., Choi, E.M., Choi, B.K., Kwon, B.S., Lee, W.H., 2006. Z39Ig is expressed on macrophages and may mediate inflammatory reactions in arthritis and atherosclerosis. J. Leukoc. Biol. 80, 922-928.
50. Lesavre, P.H., Hugli, T.E., Esser, A.F., Muller-Eberhard, H.J., 1979. The alternative pathway C3/C5 convertase: chemical basis of factor B activation. J. Immunol. 123, 529-534.
51. Makrides, S.C., 1998. Therapeutic inhibition of the complement system. Pharmacol. Rev. 50, 59-87.
52. Manderson, A.P., Botto, M., Walport, M.J., 2004. The role of complement in the development of systemic lupus erythematosus. Annu. Rev. Immunol. 22, 431-456.
53. Matsumoto, A.K., Kopicky-Burd, J., Carter, R.H., Tuveson, D.A., Tedder, T.F., Fearon, D.T., 1991. Intersection of the complement and immune systems: a signal transduction complex of the B lymphocyte-containing complement receptor type 2 and CD19. J. Exp. Med. 173, 55-64.
54. May, R.C., Caron, E., Hall, A., Machesky, L.M., 2000. Involvement of the Arp2/3 complex in phagocytosis mediated by FcgammaR or CR3. Nat. Cell Biol. 2, 246-248.
55. Mevorach, D., Mascarenhas, J.O., Gershov, D., Elkon, K.B., 1998. Complementdependent clearance of apoptotic cells by human macrophages. J. Exp. Med. 188, 2313-2320.
56. Molina, H., Holers, V.M., Li, B., Fung, Y., Mariathasan, S., Goellner, J., Strauss-Schoenberger, J., Karr, R.W., Chaplin, D.D., 1996. Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2. Proc. Natl. Acad. Sci. U.S.A. 93, 3357-3361.
57. Mollnes, T.E., Jokiranta, T.S., Truedsson, L., Nilsson, B., Rodriguez de Cordoba, S., Kirschfink, M., 2007. Complement analysis in the 21st century. Mol. Immunol. 44, 3838-3849.
58. Myones, B.L., Dalzell, J.G., Hogg, N., Ross, G.D., 1988. Neutrophil and monocyte cell surface p150,95 has iC3b-receptor (CR4) activity resembling CR3. J. Clin. Invest. 82, 640-651.
59. Nath, S.K., Han, S., Kim-Howard, X., Kelly, J.A., Viswanathan, P., Gilkeson, G.S., Chen, W., Zhu, C., McEver, R.P., Kimberly, R.P., Alarcon-Riquelme, M.E., Vyse, T.J., Li, Q.Z., Wakeland, E.K., Merrill, J.T., James, J.A., Kaufman, K.M., Guthridge, J.M., Harley, J.B., 2008. A nonsynonymous functional variant in integrin-alpha(M) (encoded by ITGAM) is associated with systemic lupus erythematosus. Nat. Genet. 40, 152-154.
60. Ogden, C.A., deCathelineau, A., Hoffmann, P.R., Bratton, D., Ghebrehiwet, B., Fadok, V.A., Henson, P.M., 2001. C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells. J. Exp. Med. 194, 781-795.
61. Ono, K., Nishitani, C., Mitsuzawa, H., Shimizu, T., Sano, H., Suzuki, H., Kodama, T., Fujii, N., Fukase, K., Hirata, K., Kuroki, Y., 2006. Mannose-binding lectin augments the uptake of lipid A, Staphylococcus aureus, and Escherichia coli by Kupffer cells through increased cell surface expression of scavenger receptor A. J. Immunol. 177, 5517-5523.
62. Oran, A.E., Isenman, D.E., 1999. Identification of residues within the 727-767 segment of human complement component C3 important for its interaction with factor H and with complement receptor 1 (CR1, CD35). J. Biol. Chem. 274, 5120-5130.
63. Pickering, M.C., Cook, H.T., Warren, J., Bygrave, A.E., Moss, J., Walport, M.J., Botto, M., 2002. Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H. Nat. Genet. 31, 424-428.
64. Pinto, A.J., Stewart, D., van Rooijen, N., Morahan, P.S., 1991. Selective depletion of liver and splenic macrophages using liposomes encapsulating the drug dichloromethylene diphosphonate: effects on antimicrobial resistance. J. Leukoc. Biol. 49, 579-586.
65. Qualmann, B., Mellor, H., 2003. Regulation of endocytic traffic by Rho GTPases. Biochem. J. 371, 233-241.
66. Ricklin, D., Lambris, J.D., 2007. Complement-targeted therapeutics. Nat. Biotechnol. 25, 1265-1275.
67. Rutherford, B., Schenkein, H.A., 1983. C3 cleavage products stimulate release of prostaglandins by human mononuclear phagocytes in vitro. J. Immunol. 130, 874-877.
68. Sahu, A., Lambris, J.D., 2001. Structure and biology of complement protein C3, a connecting link between innate and acquired immunity. Immunol. Rev. 180, 35-48.
69. Shi, Y., Tohyama, Y., Kadono, T., He, J., Shahjahan Miah, S.M., Hazama, R., Tanaka, C., Tohyama, K., Yamamura, H., 2006. Protein-tyrosine kinase Syk is required for pathogen engulfment in complement-mediated phagocytosis. Blood 107, 4554-4562.
70. Tack, B.F., Harrison, R.A., Janatova, J., Thomas, M.L., Prahl, J.W., 1980. Evidence for presence of an internal thiolester bond in third component of human complement. Proc. Natl. Acad. Sci. U.S.A. 77, 5764-5768.
71. Taniguchi-Sidle, A., Isenman, D.E., 1994. Interactions of human complement component C3 with factor B and with complement receptors type 1 (CR1, CD35) and type 3 (CR3, CD11b/CD18) involve an acidic sequence at the N-terminus of C3 alpha'-chain. J. Immunol. 153, 5285-5302.
72. Taylor, P.R., Carugati, A., Fadok, V.A., Cook, H.T., Andrews, M., Carroll, M.C., Savill, J.S., Henson, P.M., Botto, M., Walport, M.J., 2000. A hierarchical role for classical pathway complement proteins in the clearance of apoptotic cells in vivo. J. Exp. Med. 192, 359-366.
73. Thieblemont, N., Haeffner-Cavaillon, N., Haeffner, A., Cholley, B., Weiss, L., Kazatchkine, M.D., 1995. Triggering of complement receptors CR1 (CD35) and CR3 (CD11b/CD18) induces nuclear translocation of NF-kappa B (p50/p65) in human monocytes and enhances viral replication in HIV-infected monocytic cells. J. Immunol. 155, 4861-4867.
74. Trouw, L.A., Blom, A.M., Gasque, P., 2008. Role of complement and complement regulators in the removal of apoptotic cells. Mol. Immunol. 45, 1199-1207.
75. Truedsson, L., Bengtsson, A.A., Sturfelt, G., 2007. Complement deficiencies and systemic lupus erythematosus. Autoimmunity 40, 560-566.
76. Vines, C.M., Potter, J.W., Xu, Y., Geahlen, R.L., Costello, P.S., Tybulewicz, V.L., Lowell, C.A., Chang, P.W., Gresham, H.D., Willman, C.L., 2001. Inhibition of beta 2 integrin receptor and Syk kinase signaling in monocytes by the Src family kinase Fgr. Immunity 15, 507-519.
77. Vogt, L., Schmitz, N., Kurrer, M.O., Bauer, M., Hinton, H.I., Behnke, S., Gatto, D., Sebbel, P., Beerli, R.R., Sonderegger, I., Kopf, M., Saudan, P., Bachmann, M.F., 2006. VSIG4, a B7 family-related protein, is a negative regulator of T cell activation. J. Clin. Invest. 116, 2817-2826.
78. Walker, M.G., 2002. Z39Ig is co-expressed with activated macrophage genes. Biochim. Biophys. Acta 1574, 387-390.
79. Walport, M.J., 2001. Complement. First of two parts. N. Engl. J. Med. 344, 1058-1066.
80. Wiesmann, C., Katschke, K.J., Yin, J., Helmy, K.Y., Steffek, M., Fairbrother, W.J., McCallum, S.A., Embuscado, L., DeForge, L., Hass, P.E., van Lookeren Campagne, M., 2006. Structure of C3b in complex with CRIg gives insights into regulation of complement activation. Nature 444, 217-220.
81. Zang, X., Allison, J.P., 2006. To be or not to be B7. J. Clin. Invest. 116, 2590-2593.